Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs
Recruiting now
Conditions studied: Cardiac Failure, Graft Rejection
In brief
This study aims to discover circulating microRNAs (associated with drug doses and levels) that can be used to characterize the overall immune state in pediatric heart transplant patients and predict patients that will go on to develop infection and rejection. MicroRNAs (miRs) are small, non-coding RNA molecules that regulate gene expression and serve as molecular biomarkers found in the circulation.
Key facts
- Study ID
- NCT06532890
- Run by
- Inova Health Care Services
- People needed
- 150
- Starts
- 2025-02-06
- Expected to finish
- 2029-10-01
- Last updated by the study team
- 2026-03-25
Who can join
Age: any, up to 18. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age ≤ 18 years at time of transplant listing
- Subject is within 10-50 days post-orthotopic heart transplant at time of enrollment.
- Planned follow-up at the transplant center for a minimum of one-year.
- Caregiver able and willing to comply with the study visit schedule, study procedures, and study requirements.
You may not qualify if…
- Recipient of a multi-organ transplant
- History of prior solid organ transplant before the index heart transplant
- Ongoing mechanical circulatory support or hemodynamic instability after transplant
- Active infection requiring either a) hospitalization or b) treatment with antimicrobial drugs (does not include prophylaxis for infection or suppressive antibiotics given after transplant)
- History of treated rejection prior to study enrollment
- Inability to collect specified blood volume after enrollment and prior to 50 days post-transplant
Where it is running
- Children's Hospital Colorado — Aurora, Colorado, United States (enrolling)
- University of Michigan — Ann Arbor, Michigan, United States (enrolling)
- Columbia University — New York, New York, United States (enrolling)
- University of Pittsburgh — Pittsburgh, Pennsylvania, United States (enrolling)
- Vanderbilt University — Nashville, Tennessee, United States (enrolling)
- Texas Children's Hospital — Houston, Texas, United States (enrolling)
- Inova Health System — Falls Church, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.